- Supported exchanges /
- F /
- 7QS.F
FILAMENT HEALTH CORP. (7QS F) stock market data APIs
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. Its leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. The company also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, it provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
FILAMENT HEALTH CORP. Financial Data Overview
| 0.01 | |
| 0.0135 | |
| - | |
| 0.0135 | |
| 0.01 | |
| 0.009-0.114 | |
| 9 148 K | |
| 262 M | |
| 2 476 K | |
| -0.01 | |
| 1.028 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
FILAMENT HEALTH CORP. Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 476 K
- EBITDA -3 645 664
- Earnings Per Share -0.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get FILAMENT HEALTH CORP. Earnings via APIs
- Latest Release 2022-11-10
- EPS/Forecast -0.02
Get FILAMENT HEALTH CORP. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
